Cargando…
Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis
BACKGROUND: Moderate to severe plaque psoriasis has a serious effect on health-related quality of life. Patients treated with biologic medications place importance on satisfaction and treatment frequency options. We assessed patient-reported treatment satisfaction and dosing frequency choice with bi...
Autores principales: | Zhang, Mingliang, Brenneman, Susan K, Carter, Chureen T, Essoi, Breanna L, Farahi, Kamyar, Johnson, Michael P, Lee, Seina, Olson, William H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476483/ https://www.ncbi.nlm.nih.gov/pubmed/26124643 http://dx.doi.org/10.2147/PPA.S85773 |
Ejemplares similares
-
A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis
por: Pariser, David, et al.
Publicado: (2016) -
Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Ren, Vicky, et al.
Publicado: (2013) -
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Sekhon, Sahil, et al.
Publicado: (2017) -
Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
por: Light, Jeremy G, et al.
Publicado: (2021) -
Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation
por: Odnopozova, Liudmila, et al.
Publicado: (2022)